Resistance training works by creating mechanical tension in muscle fibres and generating metabolic stress that signals the body to repair and strengthen the tissue. During a caloric deficit, this signal competes with the catabolic signals of energy restriction. When resistance training is adequate in frequency, volume, and progressive load, it consistently outcompetes the catabolic signal and preserves lean mass to a degree that neither protein alone nor medication alone achieves.
What the Evidence Specifically Shows for GLP-1 Users
The STEP-HFpEF trial, published in Nature Medicine in 2023, examined semaglutide combined with exercise in adults with heart failure and obesity. Participants who combined semaglutide with structured exercise, including resistance training, preserved significantly more lean mass and achieved superior improvements in physical function compared to those receiving semaglutide alone. The exercise group also showed greater reductions in inflammatory markers, suggesting additive anti-inflammatory benefits beyond body composition.
A 2024 review in Obesity Reviews, examining all published GLP-1 trials with body composition data, concluded that exercise during GLP-1 treatment was the most effective intervention for attenuating lean mass loss. The review found that trials without structured exercise protocols lost between 25 and 40 percent of total weight as lean mass, while trials or sub-groups with regular resistance training maintained lean mass proportion more effectively.
The Minimum Effective Dose of Resistance Training
Three sessions per week targeting all major muscle groups with progressive overload represents the evidence-based minimum for meaningful lean mass preservation during caloric restriction. Progressive overload means increasing the load, volume, or difficulty of exercises over time: the body adapts quickly to any fixed stimulus and requires ongoing challenge to continue preserving and building muscle tissue.
For adults new to resistance training or returning after a significant break, starting with bodyweight movements and machines before progressing to free weights is the appropriate approach. Hip hinges, squats, pressing, rowing, and loaded carry patterns cover the major movement requirements. Sessions of 30 to 45 minutes, three times per week, are sufficient when structured around these compound patterns rather than isolated single-muscle exercises.
Starting Before GLP-1 Treatment Begins
Establishing a resistance training habit before starting GLP-1 medication produces several advantages. Initial neuromuscular adaptation to resistance training takes four to six weeks and is accompanied by fatigue and muscle soreness that reduces motivation. Completing this adaptation period before the nausea, fatigue, and appetite suppression of the early GLP-1 dose escalation phase allows the two challenging adjustment periods to occur sequentially rather than simultaneously. It also establishes the habit and movement patterns while energy levels and food intake remain normal.
- Three sessions per week targeting all major muscle groups: the evidence-based minimum
- Progressive overload is essential: the stimulus must increase over time to maintain the preservation signal
- Compound movements: squat, hinge, push, pull, and carry patterns cover all major groups efficiently
- Sessions of 30 to 45 minutes are sufficient when structured around compound movements
- Begin training before starting GLP-1 medication to separate the adaptation periods
- STEP-HFpEF trial: combined exercise and semaglutide preserved more lean mass than medication alone
- Resistance training also improves insulin sensitivity independently of weight loss: additive metabolic benefit